Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut−Brain Interaction): A Rome Foundation Working Team Report (original) (raw)

Central Neuromodulators for Treating Functional GI Disorders: A Primer

Douglas Drossman

American Journal of Gastroenterology, 2017

View PDFchevron_right

Treatment of Residual Inflammatory Bowel Disease Symptoms With Low-dose Tricyclic Antidepressants

Douglas Drossman

Journal of Clinical Gastroenterology, 2014

View PDFchevron_right

Psychopharmacologic and behavioral treatments for functional gastrointestinal disorders

Douglas Drossman

Gastrointestinal endoscopy clinics of North America, 2009

View PDFchevron_right

Evolving concepts in functional gastrointestinal disorders: Promising directions for novel pharmaceutical treatments

Gervais Tougas

2002

View PDFchevron_right

Beyond Tricyclics: New Ideas for Treating Patients With Painful and Refractory Functional Gastrointestinal Symptoms

Douglas Drossman

2009

View PDFchevron_right

Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis

Shekoufeh Nikfar

World journal of …, 2009

View PDFchevron_right

The red secTion 2897 Beyond Tricyclics: New Ideas for Treating Patients With Painful and Refractory Functional Gastrointestinal Symptoms

Douglas Drossman

View PDFchevron_right

The use of psychotropic drugs in irritable bowel syndrome

Roy Dekel, Ami D Sperber

Expert Opinion on Investigational Drugs, 2013

View PDFchevron_right

Pharmacological and Pharmacokinetic Aspects of Functional Gastrointestinal Disorders

Michael Camilleri

2006

View PDFchevron_right

A survey of pharmacological and nonpharmacological treatment of functional gastrointestinal disorders

Bruno Annibale, Michele Cicala

United European gastroenterology journal, 2013

View PDFchevron_right

Drugs targeting functional bowel disorders: insights from animal studies

G. Sanger

Current Opinion in Pharmacology, 2002

View PDFchevron_right

Centrally targeted pharmacotherapy for chronic abdominal pain

Douglas Drossman

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 2015

View PDFchevron_right

Systematic review of modulators of benzodiazepine receptors in irritable bowel syndrome: Is there hope?

Pooneh Salari

World Journal of Gastroenterology: WJG, 2011

View PDFchevron_right

Pain Management in Functional Gastrointestinal Disorders

Antonio Vigano

Canadian Journal of Gastroenterology

View PDFchevron_right

Atypical Antipsychotic Quetiapine in the Management of Severe Refractory Functional Gastrointestinal Disorders

Douglas Drossman

Digestive Diseases and Sciences, 2009

View PDFchevron_right

Neuromodulators in the Brain-Gut Axis: their Role in the Therapy of the Irritable Bowel Syndrome

Mihaela Stanculete

Journal of Gastrointestinal and Liver Diseases, 2021

View PDFchevron_right

Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment

David Alpers

World journal of gastroenterology : WJG, 2007

View PDFchevron_right

Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome

Jean Muris

Reviews, 1996

View PDFchevron_right

Is clinical response to tricyclic antidepressants in functional bowel disorders related to dosage?

Douglas Drossman

Gastroenterology, 2003

View PDFchevron_right

The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders

Michael Gershon

2007

View PDFchevron_right

Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article

Jawad ILham

Anesthesiology and Pain Medicine, 2017

View PDFchevron_right

The balancing act: endogenous modulation of pain in functional gastrointestinal disorders

Clive Wilder-smith

Gut, 2011

View PDFchevron_right

Tu1618 – Patients with Functional Gastrointestinal Disorders (FGIDS) Benefit from a Multidisciplinary Integrated Treatment Approach to Reduce Anxiety and Depressive Symptoms

Jane Campos

Gastroenterology, 2019

View PDFchevron_right

Functional gastrointestinal disorders: advances in understanding and management

Douglas Drossman

The Lancet, 2020

View PDFchevron_right

Anxiolithics and Antidepressants in the Treatment of Irritable Bowel Syndrome

Daniela Radu

View PDFchevron_right

Therapeutic management of gastrointestinal disorders

Oana Dragostin

Romanian Journal of Pharmaceutical Practice

View PDFchevron_right

Hormones of the gut�brain axis as targets for the treatment of upper gastrointestinal disorders

G. Sanger

Nat Rev Drug Discov, 2008

View PDFchevron_right

Antidepressant therapy in 138 patients with irritable bowel syndrome: a five‐year clinical experience

David Alpers

Alimentary Pharmacology & Therapeutics, 2007

View PDFchevron_right

Targeting functional gastrointestinal disorders

Jackie Wood

Current Opinion in Pharmacology, 2006

View PDFchevron_right

Current and novel therapeutic options for irritable bowel syndrome management

Viola Andresen

Digestive and Liver Disease, 2009

View PDFchevron_right

Serotonergic modulation of visceral sensation: lower gut

Michael Camilleri

Gut, 2002

View PDFchevron_right

Functional Gastrointestinal Disorders: An Update for the Psychiatrist

Paul Wiesel

Psychosomatics, 2007

View PDFchevron_right